Abstract
The pyrimido-pyrimidine analogue RA 233 has pleiotropic and differential effects on cultured tumor cell clones isolated from the 13762NF rat mammary adenocarcinoma. A nonresponsive clone of low metastatic potential (MTC) was not modified in its cell fragility or invasive, adhesive or lung-colonizing properties by RA 233 treatment. In contrast, a drug-responsive clone of high metastatic potential (MTLn3) was rendered less invasive and its cell fragility was decreased with RA 233 treatment, although its adhesiveness to lung microvascular endothelial cells and subendothelial matrix was unaffected by RA 233. Lung colonization of intravenously injected MTLn3 cells in syngeneic rats was significantly increased by RA 233 treatment, whereas spontaneous metastasis from the mammary fat pad to lung sites was decreased, although this decrease was not statistically significant.
Similar content being viewed by others
References
Ambrus, J. L., Ambrus, C. M., Gastpar, H., Huberman, E., Montagna, R., Biddle, W., Leong, S., andHoroszewicz, J., 1982,Interaction of Platelets and Tumor Cells.Progress in Clinical and Biological Research (New York: Alan R. Liss, Inc.), pp. 97–108.
Ambrus, J. L., Ambrus, C. M., andGastpar, H., 1978, Studies on platelet aggregationin vivo. VI. Effect of pyrimido-pyrimidine derivative (RA 233) on tumor cell metastasis.Journal of Medicine,9, 183–186.
Belloni, P. N., andNicolson, G. L., 1988, Differential expression of cell surface glycoproteins on organ-derived murine vascular endothelia and endothelial cells.Journal of Cellular Physiology, in press.
Biddle, W., Montagna, R. A., Leong, S. S., Horoszewics, J., Gastpar, H., andAmbrus, J. L., 1984, Antineoplastic effect of the pyrimido-pyrimidine derivative: RA 233.Pathology and Biology,32, 9–13.
Cucuianu, M. P., Nishizawa, E. E., andMustard, J. F., 1971, Effect of pyrimido-pyrimidine compounds on platelet function.Journal of Laboratory Medicine,77, 958–974.
Donati, M. B., Poggi, A., Mussoni, A., Degaetano, G., andGarattini, S., 1977,Cancer Invasion and Metastasis: Biological Mechanisms and Therapy (New York: Raven Press), pp. 151–160.
Erkell, L. J., andSchirrmacher, V., 1988, A quantitativein vitro assay for tumor cell invasion through extracellular matrix (ECM) or into protein gels.Cancer Research (In press).
Gabor, H., andWeiss, L., 1986, Perturbations in cancer cell deformability and resistance to shear forces.Invasion and Metastasis,6, 166–179.
Gardner, R. V., Tebbi, C. K., andAmbrus, J. L., 1980, The comparison ofin vitro andin vivo effects of phosphodiesterase inhibitors-prostaglandin I2 releasers on granulopoiesis.Journal of Medicine,11, 361–376.
Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T., andMurphy, S., 1973, Platelettumor cell interactions in mice. The role of platelets in the spread of malignant disease.International Journal of Cancer,11, 704–718.
Gastpar, H., Ambrus, J. L., andAmbrus, C. M., 1982,Interaction of Platelets and Tumor Cells.Progress in Clinical and Biological Research (New York: Alan R. Liss, Inc.), pp. 63–82.
Hart, I. R., Raz, A., andFidler, I. J., 1980, Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells.Journal of the National Cancer Institute,64, 891–899.
Hassanein, A. A., Turpie, A. G. G., McNicol, G., andDouglas, A. S., 1970, Effect of RA 233 on platelet functionin vitro.British Medical Journal,2, 83–86.
Hilgard, P., Heller, H., andSchmidt, C. G., 1976, The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL).Zeitschrift für Krebsforschung und Klinische Onkologie,86, 243–250.
Honn, K. V., 1983, Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.Clinical and Experimental Metastasis,1, 103–114.
Irimura, T., Gonzalez, R., andNicolson, G. L., 1981, Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.Cancer Research,41, 3411–3418.
Iwamoto, Y., Robey, F. A., Graf, J., Sasaki, M., Kleinman, H. K., Yamada, Y., andMartin, G. R., 1987, YIGSR, a synthetic laminin penta peptide, inhibits experimental metastasis formation.Science,238, 1132–1134.
Li, X.-T., andHellmann, K., 1983, Effect of RA 233 alone and combined with radiation on experimental tumour metastasis.Clinical and Experimental Metastasis,1, 51–59.
Li, X.-T., andHellmann, K., 1983, Antitumor effect of RA 233 alone and combined with radiotherapy.Clinical and Experimental Metastasis,1, 181–190.
Lichtner, R. B.,Gallick, G. E., andNicolson, G. L., 1988, Modulation of the growth-promoting activity of EGF in cultured 13762NF rat mammary adenocarcinoma cells by RA 233.Journal of Cellular Physiology, in press.
Lichtner, R. B., Goka, T. J., Butcher, R. W., andNicolson, G. L., 1987, Direct effects of the pyrimido-pyrimidine derivative RA 233 (Rapenton) on rat 13762NF mammary tumor cell clonesin vitro.Cancer Research,47, 1870–1877.
Lichtner, R. B., andHaarmann, K., 1982,Interactions of Platelets and Tumor Cells: Progress in Clinical and Biological Research (NewYork: Alan R. Liss, Inc.), pp. 131–141.
Lichtner, R. B., Hutchinson, G., andHellmann, K., 1985, Antiplatelet pyrimido-pyrimidines and metastasis.Cancer Treatment Reviews,12, 221–234.
Lichtner, R. B., andNicoloson, G. L., 1987, Effects of the pyrimido-pyrimidine derivative RX-RA 85 on metastatic tumor cell-vascular endothelial cell interactions.Clinical and Experimental Metastasis,5, 219–231.
Lichtner, R. B., andNicolson, G. L., 1987, Effects of the pyrimido-pyrimidine derivatives RA 233 and RX-RA 85 on the growth and cytoskeletal organization of rat mammary adenocarcinoma cells.European Journal of Cancer and Clinical Oncology,23, 1269–1275.
Lichtner, R. B., andWedderburn, N., 1984, Enhancement of the immune response to sheep erythrocytes by phosphodiesterase-inhibiting dipyridamole derivatives.Journal of Immunopharmacology,6, 43–55.
Lotan, R., andNicolson, G. L., 1988, Can anticancer therapy be improved by sequential use of cytotoxic and cytostatic (differentiating or immunomodulating) agents to suppress tumor cell phenotypic diversification.Biochemical Pharmacology,37, 149–154.
Maniglia, C. A., Tudor, G., Gomez, J., andSartorelli, A., 1982, The effect of 2,6-bis(diethanolamin)-4-piperidinopyrimido 5,4-pyrimidine (RA 233) on growth, metastases, and lung colony formation of B16 melanoma.Cancer Letters,16, 253–260.
Mareel, M. M., andDe Brabander, M., 1978, Effect of microtubule inhibitors on malignant invasionin vitro.Journal of the National Cancer Institute,41, 2349–2359.
Mareel, M. M., andDe Mets, M. J., 1984, Effect of microtubule inhibitors on invasion and on related activities of tumor cells.International Review of Cytology,90, 125–162.
Neri, A., Welch, D., Kawaguchi, T., andNicolson, G. L., 1982, The development and biological properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.Journal of the National Cancer Institute,68, 507–517.
Nicolson, G. L., 1982, Cancer metastasis: Organ colonization and the cell surface properties of malignant cells.Biochimica et Biophysica Acta,695, 113–176.
Nicolson, G. L., andCustead, S. E., 1985, Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity.Cancer Research,45, 331–336.
Nicolson, G. L., Fidler, I. J., andPoste, G., 1986, Effects of tertiary amine local anesthetics on the blood-borne implantation and cell surface properties of metastatic mouse melanoma cells.Journal of the National Cancer Institute,76, 511–519.
Nicolson, G. L., Irimura, T., Gonzalez, R., andRouslahti, E., 1981, The role of fibronectin in adhesion of metastatic melanoma cells to endothelial cells and their basal lamina.Experimental Cell Research,135, 464–465.
Nicolson, G. L., andLotan, R., 1986, Preventing diversification of malignant tumor cells during therapy.Clinical and Experimental Metastasis,4, 231–236.
Ryd, W., andHagmar, B., 1984, The elimination of i.v. injected tumor cells. Studies with125IUDR labelled cells in four syngeneic murine tumor systems.Acta Pathologica et Microbiologica Scandinavica Sect. A,92, 23–30.
Schneider, B.,Geser, C., andFeuerer, W., 1987, Effect of anticoagulant treatment with RA 233 (Mopidamole) on survival in bronchial cancer.XI International Congress of Thrombosis and Haemostasis, Brussels, abstract, 1872.
Segaloff, A., 1966, Hormones and breast cancer.Recent Progress in Hormone Research,22, 351–379.
Stackpole, C. W., Fornabio, D. M., andAlterman, A. L., 1987, Failure of orally administered RA 233 to influence B16 melanoma growth or metastasis.Clinical and Experimental Metastasis,5, 165–180.
Willmott, N., Malcolm, A., McLeod, T., Gracie, A., andCalman, K. C., 1983, Changes in anatomical distribution of tumor lesions induced by platelet-active drugs.Invasion and Metastasis,3, 32–51.
Zacharski, L. R., andMoritz, T. E., 1987, Effect of RA 233 (Mopidamole) on survival in carcinoma of the lung and colon. Final report of VA cooperative study #188.XI International Congress on Thrombosis and Haemostasis, Brussels, abstract, 1873.
Zacharski, L. R., Moritz, T. E., Baczek, L. A., Rickles, F. R., Edwards, R. L., Forman, W. B., Forcier, R. J., Cornell, C. J., Haakenson, C. M., Ballard, H. S., Crum, E. D., Johnson, G. J., Levine, J., KiHong, W., O'Donnell, J. F., Schilsky, R. L., Ringenberg, Q. S., Robert, F., Spaulding, M. B., Tornyos, K., Williams, C., Zucker, S., Faulkner, C. S., II,Eaton, W. L., andHoppel, C. L., 1988, Effect of mopidamole on survival in carcinoma of the lung and colon: Final report of veterans administration cooperative study No. 188.Journal of the National Cancer Institute,80, 90–97.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lichtner, R.B., Erkell, L.J., Schirrmacher, V. et al. Effects of RA 233 treatment on the adhesive, invasive and metastatic properties of 13762NF rat mammary tumor cells. Clin Exp Metast 7, 175–186 (1989). https://doi.org/10.1007/BF01787022
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01787022